Skip to main content
Sunshine Biopharma Inc. logo

Sunshine Biopharma Inc. — Investor Relations & Filings

Ticker · SBFM ISIN · US8677817004 LEI · 5299005Y64EHRQDQ2Q25 US Manufacturing
Filings indexed 382 across all filing types
Latest filing 2017-04-17 Annual Report
Country US United States of America
Listing US SBFM

About Sunshine Biopharma Inc.

https://www.sunshinebiopharma.com/

Sunshine Biopharma Inc. is a pharmaceutical company engaged in the research, development, and commercialization of life-saving medicines. The company's primary focus is on various therapeutic areas, with a significant emphasis on oncology and antiviral treatments.

Recent filings

Filing Released Lang Actions
ANNUAL REPORT
Annual Report FY 2016
2017-04-17 English
NT 10-K
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25, which is a Notification of Late Filing submitted to the SEC. It specifically states that the Form 10-K for the fiscal year ended December 31, 2016, could not be filed on time and requests an extension. The document does not contain the actual 10-K report or substantive financial data but is rather an announcement regarding the delay in filing the 10-K. The document length is 4453 characters, which is relatively short and consistent with a notification rather than a full report. Therefore, according to the MENU VS MEAL RULE and the CERTIFICATION RULE, this document should be classified as a Regulatory Filing (RNS) rather than the 10-K report itself.
2017-03-30 English
PRIMARY DOCUMENT
Director's Dealing
2016-12-15 English
PRIMARY DOCUMENT
Director's Dealing
2016-12-15 English
PRIMARY DOCUMENT
Director's Dealing
2016-12-15 English
QUARTERLY REPORT
Interim / Quarterly Report Q3 2016
2016-11-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.